An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Therapeutic Solutions International Launches Veltmeyer Institute for Advanced Biologics
Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Therapeutic Solutions International (TSOI) has launched the Veltmeyer Institute for Advanced Biologics in Elk City, Idaho, aiming to provide patients access to FDA-cleared JadiCell adult stem cells for brain and lung conditions under the Right to Try Law. This initiative is led by Dr. James Veltmeyer, who has treated over 100 patients in the field. The Institute is touted as the only organization offering allogeneic stem cells cleared by the FDA for clinical trials, positioning itself as a premium destination for patients seeking cutting-edge regenerative medicine and immunotherapy.
Positive
Launch of the Veltmeyer Institute enhances patient access to FDA-cleared stem cell treatments.
Dr. James Veltmeyer's experience treating over 100 patients underlines the Institute's credibility.
The Veltmeyer Institute provides legal access to advanced medical treatments in the U.S.
Negative
None.
FDA Phase III Stem Cell Company Offers End Stage Patients Access to FDA Cleared Clinical Trial Stem Cells
ELK CITY, Idaho--(BUSINESS WIRE)--
Therapeutic Solutions International (TSOI) announced the launching of the Veltmeyer Institute for Advanced Biologics (www.veltmeyerinstitute.org). The organization is focused on providing patients access to JadiCell adult stem cells in the field of brain and lung conditions under the Right to Try Law in applicable cases.
The Veltmeyer Institute is believed to be the only organization providing allogeneic stem cells that have been cleared by the FDA for clinical trials. The Veltmeyer Institute leverages the experience of Dr. James Veltmeyer who has treated over 100 patients under the Right to Try Law in collaboration with Therapeutic Solutions International and other Biotechnology Companies.
“I have always been a strong believer that patients should not have to leave the United States to receive access to the most cutting-edge technologies,” said Dr. James Veltmeyer, who is Chief Medical Officer of Therapeutic Solutions International and Founder of the Institute that bears his name. “I am proud to have assembled a first-class team of medical and marketing professionals to develop the Veltmeyer Institute as the premium destination for patients with incurable conditions who seek access to regenerative medicine approaches as well as immunotherapy for end stage cancer.”
“I speak for the whole TSOI Family that Dr. Veltmeyer is by far the kindest, most knowledgeable, and most effective medical doctor that we have worked quietly with all these years,” said Timothy Dixon, President, and CEO of Therapeutic Solutions International. “I am proud that we have been successful in creating this Institute which will provide a base for providing patient rapid access to stem cells and other treatments in a safe and legal way in the United States of America.”
About Therapeutic Solutions International, Inc.
Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is www.therapeuticsolutionsint.com.
